Tevogen Bio Inc.
TVGN | NASDAQ
$5.66
-$0.39 (-6.45%)
At close: Oct 30, 2026, 3:59 PM ET
$5.90
+$0.24 (+4.24%)
After-hours:
Oct 30, 2026, 7:30 PM ET
-6.45%
(1D)No price chart data available for 1D timeframe.
Rating
18.8
+2.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1000/1028 (Top 97%)
Key Statistics
Market Data
Market Cap $23.57M
1D Range
5.80 6.32
52W Range
3.89 31.42
Valuation (TTM)
PE -0.97
PB -2.65
EV/EBITDA -1.22
Valuation (NTM)
Forward PE N/A
Forward PEG -0.03
Price Target $2.00
Cash Flow
FCF Yield -49.4%
SBC Adj. FCF Yield -99.5%
SBC Impact -101.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 50.8% |
-4.7%
FCF 3Y | 5Y -12.0% |
N/A
Returns
ROA -457.1%
ROE 248.5%
ROIC -3850.2%
Financial Health
Net Debt
$1.96M
Current Ratio 0.33
Interest Coverage -133.57
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagshi...
Sector Healthcare
Industry Biotechnology
Employees 18
IPO Date Jan 5, 2022
Website tevogen.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Hold
Price Target
$2.00
Downside
-64.66%
Buy (0)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TVGN